source
- 9 biotechs will cut at least half their California workforcesWorkforce reductions have hit over 1,000 biopharma employees in The Golden State year to date, with pink slips coming from small biotechs and large pharmas. Biotechs have been hit the hardest, with…BioSpace · 1h ago↗ source
- Ramping up: 3 biotechs growing their workforce after series C raisesBiotechs that announced series C financing this year and are hiring include one that secured $140 million and has locations in London and Massachusetts.BioSpace · 1h ago↗ source
- FDA approves Infilbray, first therapy for neurological symptoms of Type 3 Gaucher diseaseThe U.S. Food and Drug Administration has approved Infilbray (venglustat) tablets for treating the neurological manifestations of Type 3 Gaucher disease in adults and children weighing at least 15…